Bluejay Diagnostics, Inc. (BJDX)
0.8366
-0.01
(-1.12%)
USD |
NASDAQ |
Oct 02, 16:00
0.83
-0.01
(-0.79%)
After-Hours: 20:00
Bluejay Diagnostics EPS Diluted (Quarterly) : -1.118 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.118 |
| March 31, 2026 | -1.949 |
| December 31, 2025 | -2.365 |
| September 30, 2025 | -4.059 |
| June 30, 2025 | -5.642 |
| March 31, 2025 | -3.365 |
| December 31, 2024 | -105.81 |
| September 30, 2024 | -307.77 |
| June 30, 2024 | -256.16 |
| March 31, 2024 | -1579.15 |
| December 31, 2023 | -743.34 |
| September 30, 2023 | -833.39 |
| Date | Value |
|---|---|
| June 30, 2023 | -1100.00 |
| March 31, 2023 | -997.20 |
| December 31, 2022 | -944.72 |
| September 30, 2022 | -1175.04 |
| June 30, 2022 | -769.12 |
| March 31, 2022 | -799.68 |
| December 31, 2021 | -580.96 |
| September 30, 2021 | -489.52 |
| June 30, 2021 | -1955.20 |
| December 31, 2020 | -342.88 |
| September 30, 2020 | -52.48 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Accuray, Inc. | -0.0154 |
| Micron Solutions, Inc. | -- |
| IDEXX Laboratories, Inc. | 4.267 |
| Neogen Corp. | -0.0519 |
| Orthofix Medical, Inc. | -0.3862 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.324M |
| Total Expenses (Quarterly) | 2.324M |
| Enterprise Value | -7.859M |
| Earnings Yield | -1.13K% |
| Normalized Earnings Yield | -1134.19 |